Recently, the “LloydsPharmacy Reusable Hot/Cold Pack”, an own label product of McKesson Europe, has won the Salute to Excellence Award from the Private Label Manufacturers Association (PLMA).

• Edward Mueller assumes role as independent chair of McKesson’s Board of Directors
• Irving, Texas officially McKesson’s new global headquarters

McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer (CEO), has decided to retire, effective March 31, 2019. McKesson’s Board of Directors has unanimously selected Brian Tyler, 51, currently president and chief operating officer (COO), to ...

McKesson Corporation today announced that Kevin Kettler has been appointed Chairman of the Management Board of McKesson Europe AG, effective 1 November 2018. Kettler will report to Brian Tyler, President and Chief Operating Officer, McKesson Corporation and Chairman of the Supervisory Board, ...

For the first time, this year McKesson Europe is part of McKesson's global Corporate Responsibility (CR) Report. The publication now combines the reports for Europe and North America, which were previously separate. As part of its CR strategy, the healthcare company is focusing on the key area ...

As a further step towards sustainable employee mobility, McKesson Europe AG is now also offering its employees hybrid and electric vehicles as company cars.

McKesson Corporation (NYSE: MCK) today announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating officer, McKesson Corporation, effective August 2, 2018. Tyler will report to chairman and CEO John Hammergren and will become a member of the executive committee.

McKesson Europe has published its first Europe-wide Corporate Responsibility Report in accordance with the international Global Reporting Initiative (GRI) guidelines.

Celesio AG is from now on McKesson Europe AG: The shareholders of the pharmaceutical wholesale and retail company had approved the renaming with an overwhelming majority during this year’s Annual General Meeting on 10 August 2017. As of today, the company appears visibly with a new brand identity.

Celesio, a leading international pharmaceutical wholesale and retail group, generated group revenue of EUR 20,644m in fiscal year 2017, down 2.6% on fiscal year 2016. Revenue in fiscal year 2017 was adversely impacted by the devaluation of the British pound and the sale of the Norwegian and ...